SWAG
IMVT icon

Spectrum Wealth Advisory Group’s Immunovant IMVT Stock Holding History

Spectrum Wealth Advisory Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.44K Buy
+219
New +$6.67K ﹤0.01% 253

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Spectrum Wealth Advisory Group's IMVT Position: Q2 2026 in Review

Spectrum Wealth Advisory Group opened a new position in Immunovant (IMVT) in Q2 2026: 219 shares worth $8.44K. The stake represents ﹤0.01% of the portfolio and ranks #253 among its holdings.

226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Spectrum Wealth Advisory Group held 219 shares of Immunovant worth $8.44K as of Q2 2026.
  • Immunovant was a new Spectrum Wealth Advisory Group position in Q2 2026.
  • Immunovant made up ﹤0.01% of Spectrum Wealth Advisory Group's portfolio in Q2 2026, its #253 holding.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Spectrum Wealth Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.